Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents.

Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations.

The American Journal of Cardiovascular Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

There are no publication charges for standard publishing in theAmerican Journal of Cardiovascular Drugs; the journal offers the option of Open Access publication via Springer Open Choice (article processing charge €3,060 / US$3,860). Please click on the link below under ‘Publishing model’ for further information about this service.

Journal information

Editor
  • Amitabh Prakash
Publishing model
Hybrid. Open Access options available

Journal metrics

2.674 (2019)
Impact factor
2.373 (2019)
Five year impact factor
28 days
Submission to first decision
105 days
Submission to acceptance
76,179 (2019)
Downloads

Latest articles

This journal has 52 open access articles

Societies, partners and affiliations

  • International Academy of Cardiovascular Sciences
    International Academy of Cardiovascular Sciences

About this journal

Electronic ISSN
1179-187X
Print ISSN
1175-3277
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Current Contents/Clinical Medicine
  4. Dimensions
  5. EBSCO Academic Search
  6. EBSCO CINAHL
  7. EBSCO Discovery Service
  8. EBSCO STM Source
  9. EMBASE
  10. Google Scholar
  11. Institute of Scientific and Technical Information of China
  12. Japanese Science and Technology Agency (JST)
  13. Journal Citation Reports/Science Edition
  14. Medline
  15. Naver
  16. OCLC WorldCat Discovery Service
  17. Pathway Studio
  18. ProQuest Central
  19. ProQuest Health & Medical Collection
  20. ProQuest Health Research Premium Collection
  21. ProQuest Medical Database
  22. ProQuest-ExLibris Primo
  23. ProQuest-ExLibris Summon
  24. Reaxys
  25. SCImago
  26. SCOPUS
  27. Science Citation Index
  28. Science Citation Index Expanded (SciSearch)
  29. Semantic Scholar
  30. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG